Copy

Newsletter 3 - ECCMID Special 2015







Join us at ECCMID

COMBACTE stands for multiple activities employed within the IMI-funded New Drugs for Bad Bugs (ND4BB) program, the European response to the growing crisis in antibiotic resistance. Establishing a high-quality clinical trial and laboratory network (CLIN-Net and LAB-Net) is a key initiative, and many of you have already joined us. With the launch of COMBACTE-MAGNET in January and COMBACTE-CARE this month, we now have three large projects up and running and study activities will grow exponentially. Read more..









Register for COMBACTE Investigators Meeting 2015

All roads lead to ECCMID 2015! Following a successful COMBACTE Investigators Meeting last year at ECCMID in Barcelona with more than a 100 participants from 19 different countries, we would like to invite you to this year’s COMBACTE Investigators Lunch Meeting in Copenhagen, Denmark. Register now!







Looking Back: 24th ECCMID, Barcelona, Spain

ECCMID 2014 ended with a total of 9,548 delegates, 10,627 (Including Industry). It is recognized by academia and the industry as the largest European congress for the presentation, discussion and networking of research in the field’s infection and microbiology. Read more..



Project Coordinator
Dr. Helen Steel
helen.m.steel@gsk.com

Academic Project Coordinator
Prof. Marc Bonten
M.J.M.Bonten@umcutrecht.nl
Academic Clinical Lead
Bruno Francois MD
bruno.francois@chu-limoges.fr

Deputy Project Co-ordinator
Seamus O'Brien
seamus.obrien@astrazeneca.com


Please contact the PMO team with your ideas for the next newsletter.
Click here to send us your thoughts! Looking forward to hearing from you!





Unsubscribe from this newsletter.

This research project receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115523 | 115620 | 115737 resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution.

Email Marketing Powered by Mailchimp